Barclays Upgrades Nutrien to Overweight, Raises Price Target to $68
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Benjamin Theurer has upgraded Nutrien (NYSE:NTR) from Underweight to Overweight and increased the price target from $64 to $68.

November 14, 2023 | 10:32 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barclays analyst Benjamin Theurer upgraded Nutrien's stock from Underweight to Overweight and raised the price target from $64 to $68.
The upgrade from Underweight to Overweight by a Barclays analyst suggests a positive change in the stock's outlook, which is likely to be viewed favorably by investors. The increase in the price target further reinforces the expectation of the stock's performance improvement. This can lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100